ATE368663T1 - Methoden zur darstellung von in 9-stellung substituierten hypoxanthinderivaten - Google Patents
Methoden zur darstellung von in 9-stellung substituierten hypoxanthinderivatenInfo
- Publication number
- ATE368663T1 ATE368663T1 AT01944675T AT01944675T ATE368663T1 AT E368663 T1 ATE368663 T1 AT E368663T1 AT 01944675 T AT01944675 T AT 01944675T AT 01944675 T AT01944675 T AT 01944675T AT E368663 T1 ATE368663 T1 AT E368663T1
- Authority
- AT
- Austria
- Prior art keywords
- derivative
- moiety
- group
- substituted
- physiologically active
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 5
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 4
- 125000003368 amide group Chemical group 0.000 abstract 3
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 abstract 3
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 imidoester derivative of aminocyanacetamide Chemical class 0.000 abstract 2
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 abstract 2
- PWWHXPQSTNMAJT-UHFFFAOYSA-N 2-amino-1h-imidazole-5-carboxamide Chemical group NC(=O)C1=CNC(N)=N1 PWWHXPQSTNMAJT-UHFFFAOYSA-N 0.000 abstract 1
- JRWAUKYINYWSTA-UHFFFAOYSA-N 2-amino-2-cyanoacetamide Chemical compound N#CC(N)C(N)=O JRWAUKYINYWSTA-UHFFFAOYSA-N 0.000 abstract 1
- DVNYTAVYBRSTGK-UHFFFAOYSA-N 5-aminoimidazole-4-carboxamide Chemical class NC(=O)C=1N=CNC=1N DVNYTAVYBRSTGK-UHFFFAOYSA-N 0.000 abstract 1
- DKGIDXRLFYRRKD-UHFFFAOYSA-N 9-[(2-methyl-4-methylidene-5-oxooxolan-2-yl)methyl]-3h-purin-6-one Chemical class C1=NC(C(N=CN2)=O)=C2N1CC1(C)CC(=C)C(=O)O1 DKGIDXRLFYRRKD-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 150000002463 imidates Chemical class 0.000 abstract 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Instrument Panels (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/602,048 US6849735B1 (en) | 2000-06-23 | 2000-06-23 | Methods of synthesis for 9-substituted hypoxanthine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE368663T1 true ATE368663T1 (de) | 2007-08-15 |
Family
ID=24409770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01944675T ATE368663T1 (de) | 2000-06-23 | 2001-06-08 | Methoden zur darstellung von in 9-stellung substituierten hypoxanthinderivaten |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6849735B1 (de) |
| EP (1) | EP1294722B1 (de) |
| CN (1) | CN1216046C (de) |
| AT (1) | ATE368663T1 (de) |
| AU (2) | AU2001267060B2 (de) |
| CA (1) | CA2415275C (de) |
| DE (1) | DE60129699T2 (de) |
| ES (1) | ES2291324T3 (de) |
| WO (1) | WO2002000659A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849735B1 (en) * | 2000-06-23 | 2005-02-01 | Merck Eprova Ag | Methods of synthesis for 9-substituted hypoxanthine derivatives |
| CN100374441C (zh) * | 2003-06-06 | 2008-03-12 | 天津倍方科技发展有限公司 | 二氢吡咯[2,3-d]嘧啶-4-酮衍生物,其制备方法及其制药用途 |
| JP2005306782A (ja) * | 2004-04-22 | 2005-11-04 | Hamari Chemicals Ltd | L−カルノシンの新規合成方法 |
| EP2235199A1 (de) | 2007-12-17 | 2010-10-06 | Lux Innovate Limited | Zusammensetzungen und verfahren zur wartung von fluidleit- und -haltesystemen |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3300380A (en) | 1963-12-26 | 1967-01-24 | Upjohn Co | Diminishing toxicity of antiviral nu6-(hydroxyalkyl) adenines with 4-hydroxypyrazolo(3, 4-d) pyrimidine |
| US3321369A (en) | 1965-05-26 | 1967-05-23 | Abbott Lab | Method of enhancing learning rate and retention level in warm blooded animals |
| US3438968A (en) | 1966-06-23 | 1969-04-15 | Int Chem & Nuclear Corp | Substituted ammonium basic addition salts of ribonucleic acid |
| BE759011A (fr) | 1969-11-17 | 1971-05-17 | Wellcome Found | Aminopurines |
| DE2554453A1 (de) | 1974-12-18 | 1976-06-24 | Experimentales Et Cliniques De | Medikament zur glykaemieregulierung |
| GB1530912A (en) | 1975-02-13 | 1978-11-01 | Wellcome Found | Compositions containing 9-(2-hydroxy-3-alkyl)-adenines |
| US4138562A (en) | 1977-02-09 | 1979-02-06 | The Regents Of The University Of Minnesota | Adenosine deaminase resistant antiviral purine nucleosides and method of preparation |
| US4221909A (en) | 1978-09-15 | 1980-09-09 | Sloan-Kettering Institute For Cancer Research | P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines |
| US4221910A (en) | 1978-09-15 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | 9-(Hydroxy alkyl)purines |
| US4221794A (en) | 1979-06-21 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | Method of imparting immunomodulating and antiviral activity |
| US4340726A (en) | 1980-03-14 | 1982-07-20 | Newport Pharmaceuticals International, Inc. | Esters |
| US4347360A (en) | 1980-09-16 | 1982-08-31 | Ens Bio Logicals Inc. | Ring open nucleoside analogues |
| US4451478A (en) | 1982-03-12 | 1984-05-29 | Newport Pharmaceuticals International, Inc. | Imidazole compounds |
| US4643992A (en) | 1982-11-09 | 1987-02-17 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
| US5093318A (en) | 1983-11-01 | 1992-03-03 | Scripps Clinic And Research Foundation | Immunostimulating guanosine derivatives and their pharmaceutical compositions |
| US4952693A (en) | 1984-10-12 | 1990-08-28 | Warner-Lambert Company | Oxazolo-pyrimidine derivatives |
| US4983494A (en) * | 1985-10-16 | 1991-01-08 | Fuji Photo Film Co., Ltd. | Image forming process including heating step |
| US5495010A (en) | 1987-04-17 | 1996-02-27 | The United States Of America As Represented By The Department Of Health And Human Services | Acid stable purine dideoxynucleosides |
| US4914028A (en) * | 1988-02-10 | 1990-04-03 | Eli Lilly And Company | Method of preparing beta-2',2'-difluoronucleosides |
| ES2091186T3 (es) | 1988-04-19 | 1996-11-01 | Pasteur Institut | Procedimiento para obtener antigenos protectores contra infecciones y procesos toxicos de bordetella. |
| IT1227389B (it) | 1988-07-07 | 1991-04-08 | Mini Ricerca Scient Tecnolog | Dispersioni acquose di polimeri uretano-acrilici e loro impiego come vernici. |
| US5256677A (en) | 1989-05-23 | 1993-10-26 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| FI921092A7 (fi) | 1989-09-15 | 1992-03-13 | Gensia Pharma | Menetelmä neurodegeneratiivisten tilojen hoitamiseksi |
| EP0433233B1 (de) * | 1989-12-14 | 1995-01-25 | Ciba-Geigy Ag | Heterocyclische Verbindungen |
| US5026687A (en) | 1990-01-03 | 1991-06-25 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds |
| US5091432A (en) | 1990-03-28 | 1992-02-25 | Glasky Alvin J | 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use |
| US5192749A (en) * | 1990-05-21 | 1993-03-09 | Syntex (U.S.A.) Inc. | 4'-substituted nucleosides |
| US5237051A (en) | 1990-12-06 | 1993-08-17 | Vanderbilt University | Purified enterotoxin receptor protein |
| US5447936A (en) | 1993-12-22 | 1995-09-05 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof |
| US5801184A (en) | 1994-07-25 | 1998-09-01 | Glasky; Alvin J. | Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
| US5795756A (en) | 1995-12-11 | 1998-08-18 | Johnson; Roger A. | Method and compounds for the inhibition of adenylyl cyclase |
| US5948771A (en) | 1996-01-31 | 1999-09-07 | The Trustees Of Columbia University In The City Of New York | Method for treating heart failure using tetrapyrroles and metallotetrapyrroles |
| US5801159A (en) | 1996-02-23 | 1998-09-01 | Galileo Laboratories, Inc. | Method and composition for inhibiting cellular irreversible changes due to stress |
| US5861532A (en) * | 1997-03-04 | 1999-01-19 | Chiron Corporation | Solid-phase synthesis of N-alkyl amides |
| CH692506A5 (de) | 1997-12-18 | 2002-07-15 | Eprova Ag | Verfahren zur Herstellung von Aminocyanacetamid. |
| AU3879899A (en) | 1998-05-04 | 1999-11-23 | Neotherapeutics, Inc. | Novel dopamine-like 9-substituted hypoxanthine and methods of use |
| AU3785799A (en) | 1998-05-04 | 1999-11-23 | Neotherapeutics, Inc. | Method for treating migraine in mammals |
| US6303617B1 (en) * | 1998-05-04 | 2001-10-16 | Neotherapeutics, Inc. | Serotonin-like 9-substituted hypoxanthine and methods of use |
| US6849735B1 (en) * | 2000-06-23 | 2005-02-01 | Merck Eprova Ag | Methods of synthesis for 9-substituted hypoxanthine derivatives |
-
2000
- 2000-06-23 US US09/602,048 patent/US6849735B1/en not_active Expired - Fee Related
-
2001
- 2001-06-08 AU AU2001267060A patent/AU2001267060B2/en not_active Ceased
- 2001-06-08 DE DE60129699T patent/DE60129699T2/de not_active Expired - Lifetime
- 2001-06-08 ES ES01944675T patent/ES2291324T3/es not_active Expired - Lifetime
- 2001-06-08 AU AU6706001A patent/AU6706001A/xx active Pending
- 2001-06-08 CN CN018144330A patent/CN1216046C/zh not_active Expired - Fee Related
- 2001-06-08 CA CA2415275A patent/CA2415275C/en not_active Expired - Fee Related
- 2001-06-08 WO PCT/US2001/040908 patent/WO2002000659A2/en not_active Ceased
- 2001-06-08 AT AT01944675T patent/ATE368663T1/de not_active IP Right Cessation
- 2001-06-08 EP EP01944675A patent/EP1294722B1/de not_active Expired - Lifetime
-
2004
- 2004-05-04 US US10/838,986 patent/US20050014943A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002000659A3 (en) | 2002-03-21 |
| US6849735B1 (en) | 2005-02-01 |
| AU2001267060B2 (en) | 2006-03-09 |
| CN1449387A (zh) | 2003-10-15 |
| AU6706001A (en) | 2002-01-08 |
| DE60129699D1 (de) | 2007-09-13 |
| CA2415275A1 (en) | 2002-01-03 |
| CA2415275C (en) | 2011-01-04 |
| DE60129699T2 (de) | 2008-04-30 |
| CN1216046C (zh) | 2005-08-24 |
| ES2291324T3 (es) | 2008-03-01 |
| US20050014943A1 (en) | 2005-01-20 |
| WO2002000659A2 (en) | 2002-01-03 |
| EP1294722A2 (de) | 2003-03-26 |
| EP1294722B1 (de) | 2007-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002363862A1 (en) | Method for producing 2-halogenacyl-3-amino-acrylic acid derivatives | |
| ATE453645T1 (de) | Verfahren zur herstellung von pyrrolotriazinverbindungen, die sich als kinaseinhibitoren eignen | |
| ES2196636T3 (es) | Ciclohexenocarboxilatos como inhibidores de la neuraminidasa. | |
| BG102100A (bg) | Методи за получаване на мономерни конюгати калихеамициново производно/носител | |
| EA200300118A1 (ru) | Тетрагидропиридино- или пиперидиногетероциклические производные | |
| WO2003046034A3 (en) | Improved synthesis of polyanhyrides | |
| WO2002085861A8 (en) | Imidazolidine compounds and their use as cxcr3 antagonists | |
| AU2003301508A1 (en) | Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production | |
| DE602005005165D1 (de) | Verfahren zur verbesserung der bioverfügbarkeit von ospemifen | |
| DE60129699D1 (de) | Methoden zur darstellung von in 9-stellung substituierten hypoxanthinderivaten | |
| AU2003235283A1 (en) | Gamma-secretase inhibitors | |
| MY116269A (en) | 5' -aminocylated-2', 3' -dideoxy -3' -fluoroguanosine hbv antivirals | |
| HUP0203812A2 (hu) | Eljárás ciklusos aminosavak sztereoszelektív előállítására | |
| Hartman et al. | Comparison of antiinflammatory and antiallergic drugs in the melittin-and D49 PLA2-induced mouse paw edema models | |
| YU24796A (sh) | Dobijanje klavulanat soli | |
| ATE265541T1 (de) | Verfahren zur fermentativen herstellung von nicht-proteinogenen l-aminosäuren | |
| DE69917615D1 (de) | Ein verfahren zur herstellung von (2s,2'r,3'r)-2-(2,3-dicarboxycyclopropyl)-glycin | |
| EE05064B1 (et) | Meetod tuntud tetrasooli derivaadi snteesiks | |
| HUP9801150A2 (hu) | N-{[2-(4-nitro-fenil)-szulfonil]-etoxi-karbonil}-aminosav-származékok, eljárás előállításukra, valamint eljárás peptidek előállítására | |
| ATE296311T1 (de) | Verfahren zur herstellung pharmakologisch verträglicher salze von n-(1(s)-ethoxycarbonyl-3- phenylpropyl)-l-alanyl aminosäuren | |
| ATE292189T1 (de) | Verfahren zur enzymatischen kinetischen trennung von 3-phenylglycidsäure durch umesterung mittels aminoalkoholen | |
| EP1270579A4 (de) | Verfahren zur herstellung von camptothectin | |
| TW344741B (en) | Process for the preparation of alkylimidazolidone (meth)acrylates | |
| ATE227289T1 (de) | Verfahren zur herstellung von azyklischen nukleosiden | |
| EP0906906A4 (de) | Verfahren zur herstellung von optisch aktiven 2-piperazincarbonsäure derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |